Anja Hviid Simonsen
Anja Hviid Simonsen
Senior Scientist, Dept of Neurology, Rigshospitalet
Verified email at
Cited by
Cited by
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
AH Simonsen, J McGuire, O Hansson, H Zetterberg, VN Podust, ...
Archives of neurology 64 (3), 366-370, 2007
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
U Rüetschi, H Zetterberg, VN Podust, J Gottfries, S Li, AH Simonsen, ...
Experimental neurology 196 (2), 273-281, 2005
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
AH Simonsen, J McGuire, VN Podust, H Davies, L Minthon, I Skoog, ...
Neurobiology of aging 29 (7), 961-968, 2008
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
AH Simonsen, SK Herukka, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 274-284, 2017
A disease state fingerprint for evaluation of Alzheimer's disease
J Mattila, J Koikkalainen, A Virkki, A Simonsen, M van Gils, G Waldemar, ...
Journal of Alzheimer's Disease 27 (1), 163-176, 2011
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
SK Herukka, AH Simonsen, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 285-295, 2017
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
AH Simonsen, B Kuiperij, OMA El-Agnaf, S Engelborghs, SK Herukka, ...
Biomarkers in medicine 10 (1), 19-34, 2016
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease versus normal aging and frontotemporal dementia
AH Simonsen, J McGuire, VN Podust, NO Hagnelius, TK Nilsson, ...
Dementia and geriatric cognitive disorders 24 (6), 434-440, 2007
A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for Alzheimer's disease
G Brinkmalm, S Sjödin, AH Simonsen, SG Hasselbalch, H Zetterberg, ...
PROTEOMICS–Clinical Applications 12 (1), 1700131, 2018
The potential of microRNAs as biofluid markers of neurodegenerative diseases–a systematic review
PB Danborg, AH Simonsen, G Waldemar, NHH Heegaard
Biomarkers 19 (4), 259-268, 2014
Biochemical markers of physical exercise on mild cognitive impairment and dementia: systematic review and perspectives
CS Jensen, SG Hasselbalch, G Waldemar, AH Simonsen
Frontiers in Neurology 6, 187, 2015
Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology
AL Petri, AH Simonsen, TT Yip, E Hogdall, ET Fung, L Lundvall, ...
Acta obstetricia et gynecologica Scandinavica 88 (1), 18-26, 2009
Pre-analytical factors influencing the stability of cerebrospinal fluid proteins
AH Simonsen, JMC Bahl, PB Danborg, V Lindstrom, SO Larsen, A Grubb, ...
Journal of neuroscience methods 215 (2), 234-240, 2013
Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design
K Hoffmann, KS Frederiksen, NA Sobol, N Beyer, A Vogel, AH Simonsen, ...
Neuroepidemiology 41 (3-4), 198-207, 2013
Cystatin C in cerebrospinal fluid and multiple sclerosis
SF Hansson, AH Simonsen, H Zetterberg, O Andersen, S Haghighi, ...
Annals of neurology 62 (2), 193-196, 2007
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
A Lleó, D Alcolea, P Martínez-Lage, P Scheltens, L Parnetti, J Poirier, ...
Alzheimer's & Dementia 15 (6), 742-753, 2019
Chasing the effects of pre-analytical confounders–a multicenter study on CSF-AD biomarkers
MJ Leităo, I Baldeiras, SK Herukka, M Pikkarainen, V Leinonen, ...
Frontiers in neurology 6, 153, 2015
The central biobank and virtual biobank of BIOMARKAPD: a resource for studies on neurodegenerative diseases
BLR Reijs, CE Teunissen, N Goncharenko, F Betsou, K Blennow, ...
Frontiers in neurology 6, 216, 2015
Amyloid β1–40 quantification in CSF: comparison between chromatographic and immunochemical methods
AH Simonsen, SF Hansson, U Ruetschi, J McGuire, VN Podust, ...
Dementia and geriatric cognitive disorders 23 (4), 246-250, 2007
The system can't perform the operation now. Try again later.
Articles 1–20